Genopathy
Gene-Disorder Association · Article
Gene
CDKN2C
Cyclin Dependent Kinase Inhibitor 2C
Disorder
Ovarian Cancer
First reported 2008
Supporting publications 2
Key publication · gene–disorder Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.Clinical cancer research : an official journal of the American Association for Cancer Research · 2008
Key publication · disorder Ovarian cancer in mother and five daughters.A.M.A. archives of pathology · 1950
Manually curated
Association Review

In brief

The association between CDKN2C (Cyclin Dependent Kinase Inhibitor 2C) and Ovarian Cancer is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 8
Compounds 0
Trials 0
Publications 2
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CDKN2C

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Ovarian Cancer

The disorder

19 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Literature

Reading

2 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
07
Provenance

References & sources

7 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access